Adiponectin receptor and gene encoding the same

Details Adiponectin receptor and gene encoding the same Adiponectin receptor and gene encoding the same

2011-07-12

2011-07-12

Shafer, Shulamith H (Department: 1647)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C435S007100, C435S810000, C436S501000

Reexamination Certificate

active

07977459

ABSTRACT:
The object is to isolate and identify human and mouse adiponectin receptors, to provide a novel protein having adiponectin binding ability, and to provide a screening method and screening kit for a ligand, agonist and antagonist to an adiponectin receptor using such protein. To achieve this object, a protein is used, as novel protein having adiponectin binding ability, that is (a) a protein comprising an amino acid sequence according to Seq. No. 2, 4, 6 or 8, or (b) a protein comprising an amino acid sequence according to Seq. No. 2, 4, 6 or 8 with one or more amino acids deleted, replaced or added, and having adiponectin binding ability.

REFERENCES:
patent: 2002/0182671 (2002-12-01), Lal et al.
patent: 2004/0067490 (2004-04-01), Zhong et al.
patent: 1074617 (2001-02-01), None
patent: 2002-191363 (2002-07-01), None
patent: 2002/383738 (2002-12-01), None
patent: WO-01/12662 (2001-02-01), None
patent: WO-01/57190 (2001-08-01), None
patent: WO-01/90304 (2001-11-01), None
patent: WO-2004-061108 (2004-07-01), None
patent: WO-2004/087874 (2004-10-01), None
patent: 2005/001061 (2005-01-01), None
Arita, Yukio et al., “Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB-Binding Protein and Regulates Growth Factor-Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell,”Circulation, vol. 105:2893-2898 (2002).
Barger, P.M., et al. “p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response.”J Biol Chem. Nov. 30, 2001; 276(48):44495-501.
Berg, A.H., et al. “The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.”Nat. Med. Aug. 2001; 7(8):947-53.
Bowie, James U. et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science, vol. 247:1306-1310 (1990).
EMBL AC No. BC024094,Mus musculus(2002).
EMBL AC No. AF151803,Homo sapiens(1999).
EMBL AC No. AK012847,Mus musculus(2001).
EMBL AC No. AK025085,Homo sapiens(2000).
Friedman, J.M. “Obesity in the new millennium.”Nature. Apr. 6, 2000; 404(6778):632-4.
Fruebis, J., et al. “Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.”Proc Natl Acad Sci USA. Feb. 13, 2001; 98(4):2005-10.
Hotamisligil, G.S. “The role of TNFalpha and TNF receptors in obesity and insulin resistance.”J Intern Med. Jun. 1999; 245(6):621-5.
Hu, E., et al. “AdipoQ is a novel adipose-specific gene dysregulated in obesity.”J Biol Chem. May 3, 1996; 271(18):10697-703.
Karpichev, I.V., et al. “Multiple regulatory roles of a novelSaccharomyces cerevisiaeprotein, encoded by YOL002c, in lipid and phosphate metabolism.”J Biol Chem. May 31, 2002; 277(22):19609-17.
Matsuzawa, Y., et al. “Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances.”Ann NY Acad Sci. Nov. 18, 1999; 892:146-54.
Michael, L.F., et al. “Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1.”Proc Natl Acad Sci USA. Mar. 27, 2001; 98(7):3820-5.
Ngo, J. Thomas et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,”The Protein Folding Problem and Tertiary Structure Prediction, K.M. Merz, Jr., ed., Chapt. 14, pp. 492-495 (1994).
Okazaki, Y., et al. “Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.”Nature. Dec. 5, 2002; 420(6915):563-73.
Ouchi, N., et al. “Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages.”Circulation. Feb. 27, 2001; 103(8):1057-63.
Puigserver, P., et al. “Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1.”Mol Cell. Nov. 2001; 8(5):971-82.
Reaven, G.M. “The fourth musketeer—from Alexandre Dumas to Claude Bernard.”Diabetologia. Jan. 1995; 38(1):3-13.
Ruderman, N.B., et al. “Malonyl-CoA, fuel sensing, and insulin resistance.”Am J Physiol. Jan. 1999; 276(1 Pt 1):E1-E18.
Scheer, A., et al. “Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.”EMBO J. Jul. 15, 1996; 15(14): 3566-78.
Shimomura, I., et al. “Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.”Nat Med. Jul. 1996; 2(7):800-3.
Shulman, G.I., et al. “Cellular mechanisms of insulin resistance.”J Clin Invest. Jul. 2000; 106(2):171-6.
Spiegelman, B.M., et al. “Adipogenesis and obesity: rounding out the big picture.”Cell. Nov. 1, 1996; 87(3):377-89.
Steppan, C.M., et al. “The hormone resistin links obesity to diabetes.”Nature. Jan. 18, 2001; 409(6818):307-12.
TheC. elegansSequencing Consortium, “Genome Sequence of the NematodeC. elegans: A Platform for Investigating Biology,”Science, vol. 282:2012-2018 (1998).
Waterston, R.H., et al. “Initial sequencing and comparative analysis of the mouse genome.”Nature. Dec. 5, 2002; 420(6915):520-62.
Wells, James A., “Additivity of Mutational Effects in Proteins,”Biochemistry, vol. 29(37:8509-8517 (1990).
Wess, J. “G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition.”FASEB J. Apr. 1997; 11(5):346-54.
White, R.T., et al. “Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.”J Biol Chem. May 5, 1992; 267(13):9210-3.
Yamauchi, Toshimasa et al., “Cloning of adiponectin receptors that mediate antidiabetic metabolic effects,”Nature; vol. 423:762-769 (2003).
Yamauchi, T., et al. “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.”Nat Med. Aug. 2001; 7(8):941-6.
Yamauchi, T., et al. “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.”Nat Med. Nov. 2002; 8(11):1288-95.
Yamauchi, T., et al. “Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.”J Biol Chem. Jan. 24, 2003; 278(4):2461-8.
Yokomizo, T., at al. “A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis.”Nature. Jun. 5, 1997; 387(6633):620-4.
Yokota, T., et al. “Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.”Blood. Sep. 1, 2000; 96(5):1723-32.
International Search Report for Application No. PCT/JP03/07515, dated Sep. 16, 2003.
Combs, Terry P., et al. “Endogenous glucose production is inhibited by the adipose-derived protein Acrp30,” The Journal of Clinical Investigation, vol. 108(12)1875-1881 (2001).

Affiliated with

Also associated with

Rating

Adiponectin receptor and gene encoding the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adiponectin receptor and gene encoding the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adiponectin receptor and gene encoding the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2735679